Hudson Bay Capital Management »

Apogee Therapeutics shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.0M 79k 75.48
2023-12-31 $559k 20k 27.94

More positions owned by Hudson Bay Capital Management

Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Amazon Call Option (AMZN)
Advanced Micro Devices Call Option (AMD)
Palantir Technologies Cl A Put Option (PLTR)
Microsoft Corporation Call Option (MSFT)
Netflix Put Option (NFLX)
Berkshire Hathaway Inc Del Cl B New Call Option (BRK.B)
Apple Call Option (AAPL)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Flagstar Bank National Assoc Com New (FLG)
Dollar Tree Call Option (DLTR)
Boeing Company Call Option (BA)

View all positions for Hudson Bay Capital Management

Top funds holding Apogee Therapeutics

VR Adviser
FMR
Wellington Management Company
BlackRock
Vanguard Group
T. Rowe Price Investment Management
Rtw Investments
Driehaus Capital Management
Fairmount Funds Management
State Street Corporation
Alliancebernstein
Perceptive Advisors
Affinity Asset Advisors
Citadel Advisors
Jpmorgan Chase & Co

View all funds holding Apogee Therapeutics